Prostate Cancer

Developing biosensor devices for better cancer diagnosis

Diagnosing cancer early on can greatly improve a patient's prognosis. Biopsies and screening are the most common and accurate means currently used to identify cancer markers in the blood. But samples have to be sent to central ...

Aug 17, 2016
popularity8 comments 0

A tiny wire with a memory to diagnose cancer

EPFL researchers have used a nanowire to detect prostate cancer with greater accuracy than ever before. Their device is ten times more sensitive than any other biosensor available.

Aug 17, 2016
popularity49 comments 0

Docs tending away from post-prostatectomy adjuvant RT

(HealthDay)—Compared with 2012, in 2015 urologists based in Australia were less favorable toward adjuvant radiotherapy for men with high-risk pathologic features post-prostatectomy, according to a study published online ...

Jul 08, 2016
popularity0 comments 0

Increasing prevalence of obesity in cancer survivors

(HealthDay)—From 1997 to 2014 the estimated rate of annual increase in obesity prevalence was higher for adults with a history of cancer, according to a study published online July 25 in the Journal of Clinical Oncology.

Aug 01, 2016
popularity46 comments 0

New insights for personalized cancer treatment

Doctors increasingly work with large quantities of digitized patient data – and yet the insights it contains often remain unexploited. Fraunhofer researchers have developed a software program that allows doctors to extract ...

Jul 01, 2016
popularity2 comments 0

Prostate cancer is a form of cancer that develops in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, there are cases of aggressive prostate cancers. The cancer cells may metastasize (spread) from the prostate to other parts of the body, particularly the bones and lymph nodes. Prostate cancer may cause pain, difficulty in urinating, problems during sexual intercourse, or erectile dysfunction. Other symptoms can potentially develop during later stages of the disease.

Rates of detection of prostate cancers vary widely across the world, with South and East Asia detecting less frequently than in Europe, and especially the United States. Prostate cancer tends to develop in men over the age of fifty and although it is one of the most prevalent types of cancer in men, many never have symptoms, undergo no therapy, and eventually die of other causes. This is because cancer of the prostate is, in most cases, slow-growing, symptom-free, and since men with the condition are older they often die of causes unrelated to the prostate cancer, such as heart/circulatory disease, pneumonia, other unconnected cancers, or old age. On the other hand, the more aggressive prostate cancers account for more cancer-related mortality than any other cancer except lung cancer. About two-thirds of cases are slow growing, the other third more aggressive and fast developing.

Many factors, including genetics and diet, have been implicated in the development of prostate cancer. The presence of prostate cancer may be indicated by symptoms, physical examination, prostate-specific antigen (PSA), or biopsy. The PSA test increases cancer detection but does not decrease mortality. Moreover, prostate test screening is controversial at the moment and may lead to unnecessary, even harmful, consequences in some patients. Nonetheless, suspected prostate cancer is typically confirmed by taking a biopsy of the prostate and examining it under a microscope. Further tests, such as CT scans and bone scans, may be performed to determine whether prostate cancer has spread.

Management strategies for prostate cancer should be guided the severity of the disease. Many low-risk tumors can be safely followed with active surveillance. Curative treatment generally involves surgery, various forms of radiation therapy, or, less commonly, cryosurgery; hormonal therapy and chemotherapy are generally reserved for cases of advanced disease (although hormonal therapy may be given with radiation in some cases).

The age and underlying health of the man, the extent of metastasis, appearance under the microscope and response of the cancer to initial treatment are important in determining the outcome of the disease. The decision whether or not to treat localized prostate cancer (a tumor that is contained within the prostate) with curative intent is a patient trade-off between the expected beneficial and harmful effects in terms of patient survival and quality of life.

This text uses material from Wikipedia licensed under CC BY-SA

Latest Spotlight News

Painkillers linked to heart failure: study

Widely used prescription and non-prescription painkillers are associated with an increased risk of hospital admission for heart failure, according to a study released Thursday.